Pricing Log in Create free account

Codexis, Inc. (CDXS) vs Protara Therapeutics, Inc. (TARA)

Codexis, Inc. and Protara Therapeutics, Inc. are both Biotechnology companies. Codexis, Inc. and Protara Therapeutics, Inc. are of similar size ($148.9M and $141.8M). Protara Therapeutics, Inc. has the higher net margin (0.00% vs −39.6%) and the lower return on invested capital (−255.1% vs −151.2%). Across the 14 metrics below, Codexis, Inc. leads on 7 and Protara Therapeutics, Inc. on 7.

Valuation

Metric CDXS TARA Biotechnology median
P/E n/m n/m 8.42
P/S 1.58 n/m 10.01
P/B 3.73 0.91 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales 1.31 n/m 9.41
Earnings yield (25.19%) (56.25%) (31.85%)
Free cash flow yield (9.90%) (45.43%) (24.58%)

Profitability

Metric CDXS TARA Biotechnology median
Gross margin 87.02% 0.00% 65.16%
Operating margin (35.61%) 0.00% 0.00%
Net margin (39.55%) 0.00% 0.00%
Free cash flow margin (15.66%) 0.00% 0.00%
Return on equity (69.36%) (45.80%) (56.36%)
Return on assets (23.79%) (42.05%) (48.04%)
Return on invested capital (151.17%) (255.06%) 0.00%

Growth

Metric CDXS TARA Biotechnology median
Revenue growth (TTM) 35.89% — 6.02%
EPS growth (last fiscal year) 43.82% 38.25% 30.26%
Revenue growth, 5-year CAGR 0.38% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CDXS TARA Biotechnology median
Debt to equity 1.03 0.00 0.00
Current ratio 3.06 10.97 4.72
Net debt to EBITDA 1.11 2.38 0.96

Dividend

Metric CDXS TARA Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric CDXS TARA Biotechnology median
Market cap 148.93m 141.83m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack